Intercept Pharma’s obeticholic acid (OCA) – trying to become the first FDA-approved therapy for non-alcoholic steatohepatitis (NASH) – will come under scrutiny by FDA advisors before the ...

President Donald Trump took office last month touting his commitment to ending wars. “My proudest legacy will be that of a ...